Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Alzumab L 100mg Injection
Manufacturer/Marketed By : ERIS LIFESCIENCES LIMITED
$317.46 $253.97
Alzumab L 100mg Injection contains an active component as Itolizumab. It is a monoclonal antibody used to treat certain autoimmune conditions, particularly moderate to severe psoriasis and rheumatoid arthritis. Monoclonal...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
ITOLIZUMAB
Active Pharmaceutical Ingredient
Alzumab L 100mg Injection
$317.46
$253.97
Alzumab L 100mg Injection contains an active component as Itolizumab. It is a monoclonal antibody used to treat certain autoimmune conditions, particularly moderate to severe psoriasis and rheumatoid arthritis. Monoclonal antibodies are synthetic proteins designed to mimic the immune system's ability to target specific substances in the body. This medication was originally developed in Cuba and has been approved for moderate to severe plaque psoriasis. It has shown promising results in studies for rheumatoid arthritis as well. This medication has generally shown good tolerability in clinical trials. Common side effects are usually mild to moderate, including infusion-related reactions, headache, dizziness, and mild gastrointestinal symptoms. Serious adverse events are relatively rare. Individuals with known hypersensitivity or severe allergic reactions to Alzumab L 100mg Injection or any of its components should avoid its use. This medication may impact the immune system, increasing the risk of infections. Patients with active infections may need to have their condition managed and the infection resolved before starting treatment. Live vaccines should be avoided during treatment since they may interfere with effectiveness. Patients should consult their healthcare provider about appropriate vaccination schedules. Individuals with certain pre-existing conditions, such as immunosuppression or a history of severe infections, may require caution due to the potential risk of further immunosuppression.
Active Pharmaceutical Ingredient
Uses
• Chronic plaque psoriasis
• Rheumatoid arthritis
Benefits
Alzumab L 100mg Injection, a monoclonal antibody drug, is therapeutic by targeting CD6, a cell surface protein found on T cells. By binding to CD6, this medication modulates the immune response, effectively controlling the activity of T cells that play a crucial role in various autoimmune disorders. In conditions like moderate to severe psoriasis and rheumatoid arthritis, where the immune system is overactive and causes inflammation and tissue damage, it helps to regulate the immune response, reducing inflammation and mitigating symptoms such as skin lesions in psoriasis and joint inflammation in rheumatoid arthritis.
Side Effects
Alzumab L 100mg Injection causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Headache
• Dizziness
• Nausea or vomiting
• Abdominal discomfort
• Diarrhea
• Fatigue
• Rash or itching at the injection site
• Infusion-related reactions (e.g., fever, chills, flushing)
Common Side Effects
• Severe allergic reactions, including rash, itching, swelling, severe dizziness, or difficulty breathing
• Infections
• Neurological events (seizures)
• Liver problems
• Anemia (decreased red blood cell)
• Decreased white blood cell
How To Use
The usage of Alzumab L 100mg Injection typically involves intravenous (IV) injection under the supervision of a healthcare professional. The prescribing doctor will determine the dosage and frequency of administration based on the specific medical condition being treated and the patient's individual response to the medication. This medication should only be administered by trained healthcare personnel in a clinical setting, and patients should follow their doctor's instructions carefully.
Safety Advice
• Breast Feeding: The safety of Alzumab L 100mg Injection during breastfeeding has not been well studied, and limited information is available regarding its excretion into breast milk. As a result, it is recommended to exercise caution when using it while breastfeeding.
• Alcohol: Since Alzumab L 100mg Injection is a biological medication that may impact the immune system and liver function, it is advisable to avoid excessive alcohol consumption while on this treatment.
• Liver: Alzumab L 100mg Injection should be used cautiously in individuals with liver conditions. A healthcare professional must closely monitor to ensure appropriate dosage and minimize potential risks.
• Lungs: Alzumab L 100mg Injection should be used with caution in individuals with lung conditions, as these conditions may affect the metabolism and elimination of the medication.
• Driving: Patients should be cautious when starting any new medication, including Alzumab L 100mg Injection, and pay attention to how their body responds to the treatment. Suppose you experience dizziness, drowsiness, or other side effects that could interfere with your driving ability. In that case, avoiding operating a vehicle or heavy machinery is essential until you feel fully alert and capable.
• Pregnancy: Limited information is available regarding its use in pregnant women. Therefore, the use of it during pregnancy should be carefully considered and evaluated by a healthcare professional, weighing the potential benefits against the potential risks.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.